Buscar
Mostrando ítems 1-10 de 41
LOSS of STRIATAL HIGH-AFFINITY NGF BINDING-SITES in PROGRESSIVE SUPRANUCLEAR PALSY BUT NOT in PARKINSONS-DISEASE
(Elsevier B.V., 1994-11-21)
I-125-Nerve growth factor (NGF) binding sites were analyzed by autoradiography in the striatum of 3 central subjects, 3 patients with Parkinson's disease and 3 patients with progressive supranuclear palsy. A high level of ...
Progressive supranuclear palsy: new concepts
(Academia Brasileira de Neurologia - ABNEURO, 2010-12-01)
Progressive supranuclear palsy (PSP) is a distinctive form of neurodegenerative disease which affects the brainstem and basal ganglia. Patients present supranuclear ophthalmoplegia, postural instability and mild dementia. ...
Whole-brain atrophy differences between progressive supranuclear palsy and idiopathic Parkinson's disease
(Frontiers Media S.A., 2016)
© 2016 Guevara, Bulatova, Barker, Gonzalez, Crossley and Kempton. Background: The absence of markers for ante-mortem diagnosis of progressive supranuclear palsy (PSP), results in this disorder being commonly mistaken for ...
Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsy
(Public Library of Science (PLoS), 2022-04-14)
The clinical and pathological spectrum of steele-richardson-olszewski syndrome (progressive supranuclear palsy) - a reappraisal
(Oxford Univ Press United Kingdom, 1995-06-01)
Seventeen patients with a progressive bradykinetic syndrome and post-mortem findings of neurofibrillary degeneration in cerebral cortex, subcortical nuclei and brainstem were studied. Seven fulfilled currently accepted ...
Differentiation of Parkinson's disease and progressive supranuclear palsy with magnetic resonance imaging: the first Brazilian experience
(Elsevier B.V., 2007-01-01)
Background: the objective of this study is to differentiate PSP from Parkinson's disease through magnetic resonance imaging. Methods: We included 14 consecutive patients with PD (9) or PSP (5). These measures included the ...
MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy
(Springer HeidelbergHeidelbergAlemanha, 2013)
Whole-brain atrophy differences between progressive supranuclear palsy and idiopathic Parkinson's disease
(Frontiers Media, 2016)
Background: The absence of markers for ante-mortem diagnosis of progressive supranuclear palsy (PSP), results in this disorder being commonly mistaken for other conditions, such as idiopathic Parkinson's disease (IPD). ...
Retrospective diagnosis of Parkinsonian syndromes using whole-brain atrophy rates
(Frontiers Research Foundation, 2017)
© 2017 Guevara, Bulatova.Objective: The absence of markers for ante-mortem diagnosis of idiopathic Parkinson's disease (IPD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) results in these disorders ...
Parâmetros na marcha na paralisia supranuclear progressiva: um estudo de caso
(Pontifícia Universidade Católica do Paraná (PUC-PR), 2012-12-01)
INTRODUÇÃO: Comprometimentos na marcha de pacientes com paralisia supranuclear progressiva (PSP) podem aumentar o risco de quedas durante o andar, especialmente em ambientes complexos. OBJETIVO: Descrever o comportamento ...